HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fernando M A Giuffrida Selected Research

NFI Transcription Factors

1/2020Update on clinical screening of maturity-onset diabetes of the young (MODY).
1/2017Maturity-onset diabetes of the young (MODY) in Brazil: Establishment of a national registry and appraisal of available genetic and clinical data.
6/2009HNF1A gene polymorphisms and cardiovascular risk factors in individuals with late-onset autosomal dominant diabetes: a cross-sectional study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Fernando M A Giuffrida Research Topics

Disease

6Type 2 Diabetes Mellitus (MODY)
06/2021 - 06/2009
4Coronary Artery Disease (Coronary Atherosclerosis)
06/2021 - 10/2011
3Hyperglycemia
06/2021 - 10/2011
3Type 2 Maturity-Onset Diabetes of the Young
11/2014 - 07/2005
3Metabolic Syndrome (Dysmetabolic Syndrome X)
12/2012 - 03/2010
2Mason-Type Diabetes
06/2021 - 01/2017
2Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2016 - 12/2012
2Obesity
01/2016 - 10/2011
2Diabetes Mellitus
08/2015 - 03/2012
2Insulin Resistance
10/2011 - 02/2006
1Iron Deficiencies
11/2021
1Body Weight (Weight, Body)
11/2021
1Glycosuria
01/2020
1Hypertension (High Blood Pressure)
01/2017
1Prediabetic State (Prediabetes)
08/2015
1Overweight
11/2014
1Dyslipidemias (Dyslipidemia)
12/2012
1Hyperinsulinism (Hyperinsulinemia)
12/2012
1Atherosclerosis
03/2010
1Cardiovascular Diseases (Cardiovascular Disease)
03/2010
1Vascular Diseases (Vascular Disease)
03/2010
1Hypertriglyceridemia
06/2009
1Hypoglycemia (Reactive Hypoglycemia)
02/2009
1Abdominal Obesity
02/2006
1Renal Insufficiency (Renal Failure)
12/2005
1Type 3 Maturity-Onset Diabetes of the Young
07/2005

Drug/Important Bio-Agent (IBA)

5GlucokinaseIBA
06/2021 - 07/2005
3NFI Transcription FactorsIBA
01/2020 - 06/2009
3Insulin (Novolin)FDA Link
01/2017 - 12/2012
3Glucose (Dextrose)FDA LinkGeneric
08/2015 - 07/2005
3AdiponectinIBA
03/2012 - 02/2006
2HDL CholesterolIBA
01/2016 - 12/2012
2Nicotinamide PhosphoribosyltransferaseIBA
08/2013 - 03/2010
2LipidsIBA
12/2012 - 06/2009
2AdipokinesIBA
03/2010 - 02/2006
1Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric
11/2021
1Alanine Transaminase (SGPT)IBA
11/2021
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
11/2021
1Ferritins (Ferritin)IBA
11/2021
1Folic Acid (Vitamin M)FDA LinkGeneric
11/2021
1Hemoglobins (Hemoglobin)IBA
11/2021
1IronIBA
11/2021
1TransferasesIBA
11/2021
1CalciumIBA
06/2021
1Apolipoproteins MIBA
01/2020
1Complement System Proteins (Complement)IBA
01/2020
1Biomarkers (Surrogate Marker)IBA
01/2020
1AntibodiesIBA
11/2014
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
12/2012
1A-factor (Streptomyces)IBA
06/2010
1Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
06/2010
1Glucagon (Glukagon)FDA Link
02/2009
1Plasminogen Activator Inhibitor 1IBA
02/2006
1LeptinIBA
02/2006
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2006
1AngiotensinogenIBA
02/2006
1ResistinIBA
02/2006
1Hepatocyte Nuclear Factor 1-alpha (Hepatocyte Nuclear Factor 1 alpha)IBA
07/2005

Therapy/Procedure

1Therapeutics
11/2021
1Bariatric Surgery
11/2021
1Glycemic Control
12/2012
1Conservative Treatment
12/2005